Sign In
Buy SMIT
$0.0150
+0 (+0%)
At Close: Jun 03, 2026
Schmitt Industries (NASDAQ:SMIT) Share Price Passes Below 200-Day Moving Average – Should You Sell?
02:46am, Thursday, 26'th Mar 2026
Shares of Schmitt Industries, Inc. (NASDAQ: SMIT - Get Free Report) passed below its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $0.02
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Schmitt Industries, Inc. (“Schmitt” or the
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Schmitt Industries, In
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming December 12, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of inves
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
10:10am, Friday, 11'th Nov 2022 Benzinga
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 156.2% to close at $0.2608 on Thursday after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions relat
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Oregon on behalf of those who acquire
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
07:31am, Tuesday, 01'st Nov 2022 Benzinga
Gainers
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Schmitt Industries, Inc. (NASDAQ: SMIT) between September 1, 2020 and September 20
Schmitt Industries, Inc. (SMIT) Class Action: Contact Robbins LLP if You Have Significant Losses in Schmitt Industries, Inc.
07:13pm, Friday, 28'th Oct 2022
SAN DIEGO--(BUSINESS WIRE)--The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons who acquired shares of Schmitt Industries, Inc. (NASDAQ: SMIT) sec
NEW YORK, Oct. 27, 2022 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Schmitt Industries, Inc. (NASDAQ: SMIT) between September 1, 2020 an
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Schmitt Industries, Inc. (SMIT) Investors
05:30pm, Monday, 24'th Oct 2022
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Oregon on behalf of those who acquire
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Schmitt Industries, Inc. (“Schmitt” or the
NEW YORK, Oct. 20, 2022 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Schmitt Industries, Inc. (NASDAQ: SMIT) between September 1, 2020 an
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming December 12, 2022 deadline to file a lead plaintiff motion in the case filed on behalf of investors who
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
09:27am, Tuesday, 18'th Oct 2022 Benzinga
Gainers
Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case
